BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15454686)

  • 1. Small fish models for identifying and assessing the effects of endocrine-disrupting chemicals.
    Ankley GT; Johnson RD
    ILAR J; 2004; 45(4):469-83. PubMed ID: 15454686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-criteria decision analysis of test endpoints for detecting the effects of endocrine active substances in fish full life cycle tests.
    Crane M; Gross M; Matthiessen P; Ankley GT; Axford S; Bjerregaard P; Brown R; Chapman P; Dorgeloh M; Galay-Burgos M; Green J; Hazlerigg C; Janssen J; Lorenzen K; Parrott J; Rufli H; Schäfers C; Seki M; Stolzenberg HC; van der Hoeven N; Vethaak D; Winfield IJ; Zok S; Wheeler J
    Integr Environ Assess Manag; 2010 Jul; 6(3):378-89. PubMed ID: 20821701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the laboratory rat as a model in endocrine disruptor screening and testing.
    Gray LE; Wilson V; Noriega N; Lambright C; Furr J; Stoker TE; Laws SC; Goldman J; Cooper RL; Foster PM
    ILAR J; 2004; 45(4):425-37. PubMed ID: 15454681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine disrupting chemicals in fish: developing exposure indicators and predictive models of effects based on mechanism of action.
    Ankley GT; Bencic DC; Breen MS; Collette TW; Conolly RB; Denslow ND; Edwards SW; Ekman DR; Garcia-Reyero N; Jensen KM; Lazorchak JM; Martinović D; Miller DH; Perkins EJ; Orlando EF; Villeneuve DL; Wang RL; Watanabe KH
    Aquat Toxicol; 2009 May; 92(3):168-78. PubMed ID: 19261338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summary of reference chemicals evaluated by the fish short-term reproduction assay, OECD TG229, using Japanese Medaka, Oryzias latipes.
    Onishi Y; Tatarazako N; Koshio M; Okamura T; Watanabe H; Sawai A; Yamamoto J; Ishikawa H; Sato T; Kawashima Y; Yamazaki K; Iguchi T
    J Appl Toxicol; 2021 Aug; 41(8):1200-1221. PubMed ID: 33486801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors considered in using birds for evaluating endocrine-disrupting chemicals.
    Touart LW
    ILAR J; 2004; 45(4):462-8. PubMed ID: 15454685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use and role of invertebrate models in endocrine disruptor research and testing.
    deFur PL
    ILAR J; 2004; 45(4):484-93. PubMed ID: 15454687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selecting appropriate animal models and experimental designs for endocrine disruptor research and testing studies.
    Stokes WS
    ILAR J; 2004; 45(4):387-93. PubMed ID: 15454677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of quantitative vitellogenin-ELISAs for fish test species used in endocrine disruptor screening.
    Nilsen BM; Berg K; Eidem JK; Kristiansen SI; Brion F; Porcher JM; Goksøyr A
    Anal Bioanal Chem; 2004 Feb; 378(3):621-33. PubMed ID: 14551668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue explant coculture model of the hypothalamic-pituitary-gonadal-liver axis of the fathead minnow (Pimephales promelas) as a predictive tool for endocrine disruption.
    Johnston TK; Perkins E; Ferguson DC; Cropek DM
    Environ Toxicol Chem; 2016 Oct; 35(10):2530-2541. PubMed ID: 26931821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Sensitivity to In Vitro Inhibition of Cytochrome P450 Aromatase (CYP19) Activity Among 18 Freshwater Fishes.
    Doering JA; Villeneuve DL; Fay KA; Randolph EC; Jensen KM; Kahl MD; LaLone CA; Ankley GT
    Toxicol Sci; 2019 Aug; 170(2):394-403. PubMed ID: 31099392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fathead minnow in aquatic toxicology: past, present and future.
    Ankley GT; Villeneuve DL
    Aquat Toxicol; 2006 Jun; 78(1):91-102. PubMed ID: 16494955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biomarkers of endocrine disruption in small model fish.
    Scholz S; Mayer I
    Mol Cell Endocrinol; 2008 Oct; 293(1-2):57-70. PubMed ID: 18619515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncertainties for endocrine disrupters: our view on progress.
    Daston GP; Cook JC; Kavlock RJ
    Toxicol Sci; 2003 Aug; 74(2):245-52. PubMed ID: 12730617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of chemical mixtures to differentiate mechanisms of endocrine action in a small fish model.
    Ankley GT; Jensen KM; Kahl MD; Durhan EJ; Makynen EA; Cavallin JE; Martinović D; Wehmas LC; Mueller ND; Villeneuve DL
    Aquat Toxicol; 2010 Sep; 99(3):389-96. PubMed ID: 20573408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of the evaluation of endocrine-disrupting chemicals in the Japanese medaka (
    Dasmahapatra AK; Williams CB; Myla A; Tiwary SK; Tchounwou PB
    Front Toxicol; 2023; 5():1272368. PubMed ID: 38090358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zebrafish (Danio rerio) as a model organism for investigating endocrine disruption.
    Segner H
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Mar; 149(2):187-95. PubMed ID: 18955160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal models and studies of in utero endocrine disruptor effects.
    Vandenbergh JG
    ILAR J; 2004; 45(4):438-42. PubMed ID: 15454682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of potential mechanisms of atrazine-induced reproductive impairment in fathead minnow (Pimephales promelas) and Japanese medaka (Oryzias latipes).
    Richter CA; Papoulias DM; Whyte JJ; Tillitt DE
    Environ Toxicol Chem; 2016 Sep; 35(9):2230-8. PubMed ID: 26792394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenoendocrine disrupters-tiered screening and testing: filling key data gaps.
    Gray LE; Ostby J; Wilson V; Lambright C; Bobseine K; Hartig P; Hotchkiss A; Wolf C; Furr J; Price M; Parks L; Cooper RL; Stoker TE; Laws SC; Degitz SJ; Jensen KM; Kahl MD; Korte JJ; Makynen EA; Tietge JE; Ankley GT
    Toxicology; 2002 Dec; 181-182():371-82. PubMed ID: 12505339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.